NCT06722807
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- University of Florida Gainesville, Florida, United States
Clinical trial condition
Carcinoma, Renal Cell
Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.
1,363 public trials
252 recruiting studies
Carcinoma, Renal Cell trial results
NCT07510334
- Conditions
- Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +18 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Recruiting
Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma
NCT07018037
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- "Regina Elena" National Cancer Institute Rome, Italy
NCT04235777
- Conditions
- Adenocarcinoma, Bladder Cancer, Carcinoma, +20 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT04777994
- Conditions
- Adenocarcinoma, Advanced Solid Tumor Cancer, Bronchial Neoplasms, +29 more
- Locations
-
- University of Arizona Cancer Center - Tucson /ID# 262698 Tucson, Arizona, United States
- Yale University School of Medicine /ID# 225707 New Haven, Connecticut, United States
- Johns Hopkins Hospital /ID# 254056 Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center /ID# 252009 Boston, Massachusetts, United States
Recruiting
SABR for Renal Tumors
NCT03747133
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- University Health Network - Princess Margaret Cancer Centre Toronto, Ontario, Canada
NCT04981119
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +65 more
- Locations
-
- Banner Health Gilbert, Arizona, United States
- Mayo Clinic Hospital Phoenix, Arizona, United States
- City of Hope Duarte, California, United States
- University of California San Diego La Jolla, California, United States
NCT07023432
- Conditions
- Active Surveillance, Adenocarcinoma, Carcinoma, +15 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT05287945
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +22 more
- Locations
-
- Stanford Palo Alto, California, United States
- Washington University in St. Louis St Louis, Missouri, United States
- University of Texas - MD Anderson Cancer Center Houston, Texas, United States
- START Lisbon - Hospital de Santa Maria Av Lisbon, Portugal
Recruiting
Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma
NCT06053658
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- City of Hope Irvine, California, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- University of Michigan Ann Arbor, Michigan, United States